Skip to main content
. 2022 Dec 21;12(12):e062930. doi: 10.1136/bmjopen-2022-062930

Table 1.

Sociodemographic and clinical factors of eligible focus Consortium participants at baseline (n=2401)

Overall ColoCare HD ColoCare FHCRC ColoCare HCI COLON CORSA EnCoRe
n (%) 2401 (100) 298 (12.4) 150 (6.3) 80 (3.3) 1338 (55.7) 218 (9.1) 317 (13.2)
Age
 Mean year±SD 65.4±10.2 63.7±12.2 58.3±12.8 61.3±11.2 66.1±8.7 67.3±12.0 66.9±9.3
Sex
 Female n (%) 864 (36.0) 100 (33.6) 67 (44.7) 32 (40.0) 486 (36.3) 76 (34.9) 103 (32.5)
 Male n (%) 1537 (64.0) 198 (66.4) 83 (55.3) 48 (60.0) 852 (63.7) 142 (65.1) 214 (67.5)
Education
 Low n (%) 861 (35.9) 123 (41.3) 18 (12.0) 17 (21.3) 543 (40.6) 73 (33.5) 87 (27.4)
 Intermediate n (%) 694 (28.9) 57 (19.1) 71 (47.3) 40 (50.0) 332 (24.8) 73 (33.5) 121 (38.2)
 High n (%) 658 (27.4) 88 (29.5) 28 (18.7) 8 (10.0) 417 (31.7) 14 (6.4) 103 (32.5)
 Unknown n (%) 188 (7.8) 30 (10.1) 33 (22.0) 15 (18.7) 46 (3.4) 58 (26.6) 6 (1.9)
Marital status
 Unmarried n (%) 122 (5.1) 19 (6.4) 15 (10.0) 2 (2.5) 60 (4.5) 10 (4.6) 16 (5.1)
 Married n (%) 1738 (72.4) 193 (64.8) 71 (47.3) 50 (62.5) 1071 (80.0) 113 (51.8) 240 (75.7)
 Divorced/separated n (%) 138 (5.7) 24 (8.0) 11 (7.3) 10 (12.5) 64 (4.8) 14 (6.4) 15 (4.7)
 Widowed n (%) 194 (8.1) 31 (10.4) 7 (4.7) 1 (1.3) 90 (6.7) 26 (11.9) 39 (12.3)
 Living community n (%) 20 (0.8) 0 13 (8.7) 2 (2.5) 4 (0.3) 1 (0.5) 0
 Unknown n (%) 189 (8.9) 31 (10.4) 33 (22.0) 15 (18.7) 49 (3.7) 54 (24.8) 7 (2.2)
Smoking status
 Current n (%) 290 (12.1) 53 (17.8) 8 (5.3) 6 (7.5) 143 (10.7) 38 (17.4) 42 (13.3)
 Former n (%) 1219 (50.8) 132 (44.3) 53 (35.32) 21 (26.3) 767 (57.3) 76 (34.9) 170 (53.6)
 Never n (%) 767 (31.9) 90 (30.2) 56 (37.3) 39 (48.7) 386 (28.9) 97 (44.5) 99 (31.2)
 Unknown n (%) 125 (5.2) 23 (7.7) 33 (22.0) 14 (17.5) 42 (3.1) 7 (3.2) 6 (1.9)
Alcohol intake
 Mean g/day±SD 13.6±17.1 16.1±19.2 8.8±18.5 2.3±10.2 14.0±17.0 12.9±16.5
 Unknown n (%) 633 (26.4) 208 (69.8) 81 (54.0) 60 (75.0) 54 (4.1) 218 (100) 12 (3.8)
BMI at diagnosis
 Mean kg/m2±SD 27.1±4.6 26.6±4.1 28.7±7.3 29.4±7.5 26.6±4.0 27.7±4.4 28.3±4.6
 Unknown n (%) 42 (1.7) 2 (0.7) 0 14 (17.5) 10 (0.8) 14 (6.4) 2 (0.6)
Tumour site
 Colon n (%) 1450 (60.4) 140 (57.0) 75 (50.0) 45 (56.3) 867 (64.8) 131 (60.1) 192 (60.6)
 Rectum n (%) 862 (35.9) 143 (48.0) 60 (40.0) 22 (27.5) 434 (32.4) 78 (35.8) 125 (39.4)
 Rectosigmoid n (%) 42 (1.7) 15 (5.0) 15 (10.0) 7 (8.7) 0 5 (2.3) 0
 Unknown n (%) 47 (2.0) 0 0 6 (7.5) 37 (2.8) 4 (1.8) 0
Tumour stage
 I n (%) 629 (26.2) 76 (25.5) 35 (23.3) 21 (26.3) 326 (24.4) 82 (37.6) 89 (28.1)
 II n (%) 694 (28.9) 114 (38.3) 49 (32.7) 23 (28.7) 386 (28.9) 52 (23.9) 70 (22.1)
 III n (%) 973 (40.5) 108 (36.2) 66 (44.0) 36 (45.0) 564 (42.1) 52 (23.9) 147 (46.4)
 Unspecified* n (%) 16 (0.7) 0 0 0 4 (0.3) 12 (5.5) 0
 Unknown n (%) 89 (3.7) 0 0 0 58 (4.3) 20 (9.2) 11 (3.5)
Treatment
 Neoadjuvant chemotherapy n (%) 331 (13.8) 55 (18.5) 47 (31.3) 15 (18.8) 138 (10.3) 14 (6.4) 62 (19.6)
 Unknown n (%) 58 (2.4) 2 (0.7) 1 (0.7) 10 (12.5) 38 (2.8) 7 (3.2) 0
 Neoadjuvant radiotherapy n (%) 523 (21.8) 72 (24.2) 48 (32.0) 13 (16.3) 290 (21.7) 14 (6.4) 86 (27.1)
 Unknown n (%) 58 (2.4) 2 (0.7) 1 (0.7) 10 (12.5) 38 (2.8) 7 (3.2) 0
 Adjuvant chemotherapy n (%) 682 (28.4) 100 (33.6) 80 (53.3) 32 (40.0) 315 (23.8) 56 (25.7) 99 (31.2)
 Unknown n (%) 121 (5.0) 17 (5.7) 3 (2.0) 28 (35.0) 63 (4.7) 9 (4.1) 1 (0.3)
 Adjuvant radiotherapy n (%) 227 (9.5) 188 (63.1) 7 (4.7) 1 (1.3) 16 (1.2) 13 (6.0) 2 (0.6)
 Unknown n (%) 164 (6.8) 17 (5.7) 3 (2.0) 28 (35.0) 106 (7.9) 9 (4.1) 1 (0.3)
 Surgery n (%) 2291 (95.4) 298 (100.0) 149 (99.3) 71 (88.7) 1290 (96.4) 195 (89.5) 288 (90.9)
 Unknown n (%) 44 (1.8) 0 0 3 (3.8) 39 (2.9) 1 (0.5) 1 (0.3)

*Distinguishing between stage I and II or II and III not possible.

BMI, body mass index.